In the post-implant period, patients with cardiac rhythm management devices can expect to lead normal, active lives.

Retina-predicted cardiovascular disease scores offer an accurate and convenient way to measure atherosclerotic cardiovascular disease risk.

The moderate accuracy of ChatGPT demonstrates potential risks for both patients and physicians using this tool. Further research is required to create more accurate models.

The aim of this paper is to provide an update on advances in cardiac implantable electronic devices technology and how this applies to managing patients.

In a rapidly evolving digital world, it is crucial that general practice embraces the potential of artificial intelligence and virtual reality in a real and proactive clinical manner.